Atlas Bio is a Basel-based techbio startup building AI simulations that predict how individual patients will respond to drug treatments. Its foundation model, trained on roughly 2 million human RNA readouts, generalises across indications and treatments, helping drugmakers select indications, identify responders and compare treatments before committing to expensive Phase 2 trials, with the long-term aim of replacing parts of animal testing and clinical development.
2
Rounds
1
Industry
5
Tags
Oct 27, 2026
Latest raise
Funding activity · 2 rounds
Oct 27, 2026
$2.5M
Pre-Seed
Led by First Momentum Ventures
Article coming soon.
Oct 27, 2026
$10M
Seed
Led by Creandum
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
